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Workingmemory(WM)capacityimprovementisimpactedbysleep,andpossiblybyN-methyl-D-aspartate
(NMDA) agonists such as D-cycloserine (DCS), which also affects procedural skill performance. However,
the mechanisms behind these relationships are not well understood. In order to investigate the neural basis
underlying relationships between WM skill learning and sleep, DCS, and both sleep and DCS together, we
evaluated training-retest performances in the n-back task among healthy subjects who were given either a
placebo or DCSbeforethetask training,and thenfollowed tasktrainingsessionseitherwith wakefulnessor
sleep. DCS facilitated WM capacity enhancement only occurring after a period of wakefulness, rather than
sleep,indicating that WMcapacityenhancement isaffectedby acellular heterogeneityinsynaptic plasticity
betweentimespentawakeandtimespentasleep.Thesefindingsmaycontributetodevelopment,anti-aging
processes, and rehabilitation of higher cognition.
W
orking memory (WM) is regarded as a specific process by which a remembered stimulus is held
‘‘on-line’’toguidebehaviorintheabsenceofexternalcuesorprompts
1–3.WMcapacity,themaximum
amount of information that can be retained in the WM, is an important factor influencing problem-
solvingandreasoningabilities
4–6.The‘‘n-back’’task
7–10hasbeenutilizedtomeasureindividuals’WMcapacity,as
well as the neural basis of WM processes. Repetitive training facilitates improvements in WM capacity, an aspect
ofspatialWMperformanceassociatedwithincreasedactivitiesofrelevantcortices,includingthedorsolateraland
medialprefrontalcortices(PFC)andthesuperiorandinferiorparietalcortices
11.Moreover,improvementofWM
capacity is achieved through the off-line process of neuroplasticity during sleep
12. Significant improvements in
WMcapacitymeasuredbyaspatialn-backtaskwereobservedaftersubjectsreceivedanightofposttrainingsleep,
but not over a similar period of wakefulness; this result was seen regardless of whether time awake or time asleep
occurred first and whether subjects were initially trained during morning, midday or evening
12.
Althoughsleepplaysacrucialroleintheoff-linedevelopmentofvariousdomainsofskilllearning
13–17,delayed
skill consolidation could also occur during periods of wakefulness
18, suggesting that differences in delayed skill
consolidation during sleep and wakefulness result from corresponding differences in neural substrate
15,19,20. One
of the key excitatory neurotransmitters is glutamate
21–24. Activation of the N-methyl-D-aspartate (NMDA)
glutamate receptor mediates a long-lasting increase in synaptic potentiation at the intracellular level
25,26, which
is thought to elicit synaptic plasticity and delayed skill consolidation
27,28. Administration of NMDA receptor
antagonistscanprohibitlong-termsynapticpotentiation,thuspreventingskill-learningpracticefromtranslating
into successful skill acquisition in animals
29. On the other hand, the administration of NMDA receptor agonists
enhancesskill-learninginanimals
30,includinghumans
31.NMDAreceptor-dependentglutamatergicneurotrans-
mission contributes to the formation of long-term memory, not only within the hippocampus
32 but also within
the PFC
33. Thus, it is likely that NMDA receptor agonists enhance WM capacity improvements via enhancing
NMDA receptor-dependent synaptic plasticity in the PFC. An evidence suggesting that downregulation of
NMDA receptors results in decreased spatial WM performance
24 could also paradoxically support the notion.
In the current study, we explored delayed skill learning properties by using the n-back task
12 to examine the
effect of an NMDA partial agonist, D-cycloserine (DCS), on WM capacity improvement. DCS acts at the
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DCS is known to facilitate extinction of fear-conditioning in rats
34–36
and humans
37, as well as non-emotional skill learning
31,38. Further,
we also examined whether DCS interacted with sleep-dependent
WMcapacityimprovement.Wepredictedthatthesedatamighthelp
identify the distinct neural backgrounds underlying the differences
betweentheseskillconsolidationprocesses;further, thisinformation
could be used for developing a technique facilitating improvements
in overall human higher cognition.
Results
Psychomotor Performance. Results of the questionnaire about side
effects showed that 2–3 subjects in each treatment group (Fig. 1, see
Methods) reported drowsiness after administration of either DCS or
the placebo; however, no significant drug-induced adversities were
reported. At each training and retesting point, all subjects performed
a psychomotor vigilance task (PVT), which is a measure of the psy-
chomotor vigilance level
39. Three-way ANOVA revealed that neither
group (F1,525 0.38, p 5 0.54)nor session (F1,525 0.70,p 5 0.79)nor
sex (F1,52 5 0.04, p 5 0.84) significantly affected the simple response
time (SRT) of the PVT in groups A and B; likewise, there was also no
effect of the possible interaction terms (all F1,52 , 0.20, all p . 0.70).
Four-way ANOVA also revealed that neither session (F1,100 5 0.04,
p 5 0.84) nor medication (F1,100 5 0.14, p 5 0.71) nor inter-session
schedule (F1,100 5 2.00, p 5 0.16) nor sex (F1,100 5 2.07, p 5 0.15)
significantlyaffectedtheSRTofthePVTingroupsC–F;likewise,there
wasalsonoeffectofthepossibleinteractionterms(allF1,100,2.50,all
p . 0.12). Additionally, no subjects displayed any lapses during the
PVT.TheseresultssuggestthatsubjectsingroupsAandBorC–Fhad
similar psychomotor vigilance levels during each test session.
Sleep Length. Two-way ANOVA showed that neither group (F1,26 5
3.40, p 5 0.08) nor sex (F1,26 5 0.24, p 5 0.63) nor interaction of the
two (F1,26 5 1.51, p 5 0.23) had a significant effect on the amount of
sleep received on pre-training (group A: 6.54 6 0.13 h; group B:
7.16 6 0.26 h). Three-way ANOVA showed that neither medication
(F1,50 5 1.16, p 5 0.29) nor inter-session schedule (F1,50 5 1.49, p 5
0.23), sex (F1,50 5 2.28, p 5 0.14) nor possible interactions among
them (all F1,50 , 3.50, all p . 0.05) had a significant effect on the
amount of sleep received in pre-training (group C: 6.64 6 0.21 h;
group D: 6.75 6 0.24 h; group E: 6.57 6 0.24 h; group F: 7.15 6
0.16 h). Besides, two-way ANOVA showed that neither group
(F1,26 5 0.03, p 5 0.86; F1,26 5 1.01, p 5 0.32) nor sex (F1,26 5
0.37, p 5 0.55; F1,26 5 1.82, p 5 0.19) nor interaction between them
(F1,26 5 0.23, p 5 0.88; F1,26 5 0.85, p 5 0.77) had a significant effect
ontheamountofsleepreceivedinpost-trainingingroupsAvs.BorC
vs. E (Group A: 6.50 6 0.21 h; Group B: 6.55 6 0.22 h; Group C:
6.00 6 0.19 h; Group E: 6.32 6 0.21 h).
Initial Training Performance. Three-way ANOVA showed that
n-back accuracy level was significantly impacted by training
(F2,252 5 27.0, p , 0.0001), but not by medication (F1,252 5 0.41,
p 5 0.52) or sex (F1,252 5 2.27, p 5 0.13); the possible interaction
terms were also not significantly associated with accuracy level (all F
, 0.50, p . 0.60; Fig. 2). Subsequent post-hoc tests showed that
training significantly improved n-back accuracy level between
the first and second trials (p , 0.0001) and between the first and
third trials (p , 0.0001), but not between the second and third trials
(p 5 0.10). Although repetitive training of the n-back WM task
maximized task performance almost by the end of the second trial,
DCS administration had no effect throughout the training period.
Moreover, it is indicated that there was no sex difference in the
training performance of the n-back WM task.
Delayed Improvements in n-back Performance during Diurnal
Experimental Period. A three-way ANOVA showed that, while ses-
sion had a significant impact on n-back accuracy level (F1,52 5 22.8,
p , 0.0001), medication (F1,52 5 1.99, p 5 0.16)and sex (F1,52 5
0.004, p 5 0.95) did not during the diurnal experimental period
(groups A and B). However, there was a significant effect of the
session 3 medication interaction term (F1,52 5 4.39, p 5 0.041;
Fig. 3A), while there were not any other interaction terms (all
F1,52 , 1.0, all p . 0.45). Specifically, there was a significant
difference in improvement in the n-back accuracy level between
groups A and B (t28 5 3.21, p 5 0.003; Fig. 3B). This indicates that
although delayed improvements in n-back accuracy level were
achieved in both groups, this process was significantly facilitated
by DCS.
Figure 1 | Experimentalschedulesforeachofthe6treatmentgroups. Subjectswereassignedto3pairsofrandomized,blind,placebo-controlled,2-arm
experimental groups (A–F). Each group underwent a specific schedule consisting of an initial training session and a retest session. Subjects were
administeredencapsulated DCS(groups B,E,andF)oraplacebo (groupsA, C,andD) onanempty stomach1.5 hpriortothe training session.Subjects
in groups A and B were placed on a diurnal experimental schedule, in which they were trained at 20:00 h and were then retested at 20:00 h the next day
(e.g., 24 h later). Subjects in groups C–F were placed on a semidiurnal experimental schedule. Individuals in groups C and E were trained at 20:00 h and
wereretestedat08:00 hthefollowingday(e.g.,12 hlater)afteranightofsleep.IndividualsingroupsDandFweretrainedat08:00 handwereretestedat
20:00 h after 12 h of wakefulness. All subjects performed spatial n-back WM tasks (n 5 1–7) during each test session. All post-sleep retests were
performed at least 1 h after awakening.
www.nature.com/scientificreports
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diurnal Experimental Period. A four-way ANOVA showed that
n-back accuracy level was significantly affected by session (F1,100 5
8.82, p 5 0.004), but not by medication (F1,100 5 1.48, p 5 0.23),
schedule (F1,100 5 0.02, p 5 0.89), sex (F1,100 5 2.91, p 5 0.091), or
any of the possible interaction terms (all F1,100 , 2.0, all p . 0.10;
Fig. 4A) during the semidiurnal experimental period (groups C–F).
Atwo-wayANOVArevealedasignificanteffectofthemedication3
schedule interaction term (F1,54 5 4.75, p 5 0.034) on improvement
of n-back accuracy level, but non-significant effects of either medi-
cation (F1,54 5 0.42, p 5 0.52) or schedule (F1,54 5 0.66, p 5 0.42)
alone (Fig. 4B). Subsequent post-hoc tests revealed trends toward
significant differences between groups C and D (p 5 0.038) and
groups D and F (p 5 0.046) in the improvement of n-back accuracy
level. These findings suggest that DCS does not facilitate sleep-
dependent skill consolidation, but, rather, skill consolidation during
wakefulness.
Discussion
First of all, any sex effects on vigilance levels, sleep lengths, WM
performances, DCS effects, and interactions between WM perform-
ance and DCS effect were not observed in the current study.
A definite improvement in WM capacity was observed within 2
trials during the training session; subjects had almost reached a per-
formance plateau by the third n-back trial. Initial acquisition of WM
skill performance was not facilitated by DCS. Onur et al. suggested
that DCS does not facilitate immediate learning despite potentially
accelerating hippocampal activity
38. Thus, DCS may enhance the
encoding process and accelerate delayed, rather than immediate,
learning.
Medication and sleep quality did not significantly affect psycho-
motorvigilancelevelsin thedifferent treatment groups;however, we
did observe various group differences in the improvement of n-back
accuracy levels across training-retest sessions. Differences in groups
A (0.79%) and B (1.88%) in the improvement of n-back accuracy
level clearly indicate that DCS facilitates the improvement of WM
capacity during a 24-h post-training interval. Additionally, differ-
ences in accuracy improvements among groups C-F (C: 0.71%, D:
0.23%,E:0.47%,F:0.69%)suggestthatDCShadhigherefficacywhen
followed by wakefulness than when followed by sleep. Although
there is no evidence that DCS affects sleep architecture, our results
clearly indicate that WM capacity improvement facilitated by DCS
was not achieved via sleep modulation.
A comparison of groups B and E does not immediately explain
why the 24-h effect should emerge during the second 12 h of wake-
fulness, since DCS is probably no longer fully active during this
period. We need to compare the results of the 2 experimental groups
inwhichsubjectsfirststayedawakeandthensleptduringthediurnal
(24 h) experimental schedule with DCS or placebo administration
with those of the current study. These experimental groups would
greatly establish our claims, however, we previously confirmed that
overnight improvements in WM capacity were observed regardless
ofwhethertimeawakeortimeasleepoccurredfirst
12.Takentogether,
Figure 3 | Changes in working memory (WM) capacity between and
within testing sessions in experimental groups on the diurnal schedule
(24-hintervalbetweenthetestingsessions). (A)Then-backaccuracylevel
significantlyimprovedbetweenthetrainingandretestperiodsinbothgroups
(p , 0.0001). However, the significant session 3 medication interaction
(p 5 0.041) suggests that DCS administration facilitated the greater
improvements observed in group B. Light and dark green bars represent
n-back accuracy levels at the training and retest sessions, respectively. (B)
Inter-sessionimprovements in n-back accuracy level in groups A and B. The
n-back accuracy level improved significantly more (p , 0.005, indicated by
the asterisk) in groupB, which received the DCS treatment,than ingroupA,
which received the placebo treatment. The heights of the brown bars and
error bars represent the mean and SEM, respectively.
Figure 2 | Changes in working memory (WM) capacity during the
training period. Subjects were administered either a placebo (open circles
with dotted line; groups A, C, and D) or D-cycloserine (DCS; closed circles
with continuous line; groups B, E, and F). Subjects in both groups showed
significantimprovementsinn-backaccuracylevelsacrossthe3trials,butthe
ratesofimprovementwerenotrelatedtomedication.Bytheendoftraining,
rates of improvement in both groups had nearly plateaued, and accuracy
levelsinthe2groupsdifferedbyonly0.0660.18[mean6standarderrorof
the mean (SEM)]. The heights of the circles and error bars represent means
and SEMs, respectively. Asterisks (**) indicate p , 0.0001.
www.nature.com/scientificreports
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process, with delayed onset of action only occurring after a period of
wakefulness, rather than sleep. The remaining question is whether
theDCSinteracts withsleeptohaveanimpactonWMcapacity.The
results from groups C–F suggest that it does not. The largest
improvement, observed after 24 h in group B, may result from sim-
ple integration of separate delayed improvements from the sleep-
dependent skill consolidation process (robustly reflected in group
C) and the DCS-facilitated skill consolidation process (robustly
reflected in group F).
The other limitation remained that although DCS does not
directly facilitate immediate learning of the WM skill, there is debate
over whether DCS facilitates the consolidation process of the WM
skill or merely facilitates delayed performance of the WM skill.
Especially in semidiurnal experimental groups, DCS could act to
even retest performances due to the long half-life of DCS
40.I fW M
skillperformanceperseisfacilitatedbycurrentenhancementofDCS
bindingactivityoftheNMDAreceptor,initialtrainingperformances
could be much enhanced and retest performances of the diurnal
experimental groups could be less enhanced than retest perfor-
mances of the semidiurnal experimental groups. Therefore, the cur-
rent results suggest that DCS acts within the neuroplastic process
during the delayed consolidation process that occurs in wakefulness.
Heterogenous neuroplastic processes seem to develop with WM
capacity improvement during both sleep and wakefulness. During
wakefulness, WM capacity improvement may have resulted from a
delayed memory consolidation process driven by the cellular mech-
anismoflong-termpotentiation
41–43,whichcouldbefacilitatedbyan
NMDA agonist. However, during the sleep period, there may have
been an additional delayed learning process dependent not on a
given cellular long-term potentiation mechanism but on a novel
mechanism by which neuroplasticity contributes to skill consolida-
tion. A likely explanation is that sleep-dependent skill consolidation
is generated via a reassembly of the cortical networks
11,44 and may be
independent of the synaptic-level consolidation process associated
with NMDA receptor-dependent neuroplasticity. Changes in cor-
tical activity have been observed in response to 5 weeks of WM
training
11. These include increases in activity in the middle frontal
gyrus and superior and inferior parietal cortices, which may be con-
sequences of the reorganization of reassembly activation patterns in
the connections of both intracellular
45 and intracortical
46 levels.
Delayed learning processes during sleep and wakefulness possibly
share these roles in consolidating skill over an extended period of
time. Although these neuronal reorganizations in 2 different levels
may not be mutually exclusive
44, our results suggest the neuronal
reorganization of intracellular level predominantly occurs during
wakefulness while that of the intracortical level predominantly
occurs during sleep. Thus, DCS is able to enhance only the
neuronal reorganization of intracellular level during wakefulness.
Additionally, a previous study investigating motor skill improve-
ment suggested that qualitatively different aspects of delayed learn-
ing resulted from intervals of sleep versus wakefulness
47. A similar
process may occur during WM capacity improvement.
MK-801 (dizocilpine), an NMDA glutamate receptor antagonist,
has been shown to impair the consolidation of spatial WM skill
learningacross severaldays inanimals
29.Onthe otherhand,another
NMDA antagonist, amantadine, is not known to impair simple
motorskillconsolidation inhumans
48.However,whenadministered
to human subjects, the NMDA antagonists caroverine and ketamine
preventdelayedconsolidationofvisualproceduralskilllearningdur-
ing sleep without affecting sleep architecture
49. These findings seem
to be restricted to each skill domain. However, when they are
considered together with our current results, they suggest that the
activity of the glutaminergic synapses during sleep and wakefulness
could play complementary roles for skill consolidation; specifically,
while consolidation of skill (including WM capacity) may occur
predominantly during sleep, this process may not proceed during
wakefulness until exposure to a glutaminergic receptor stimulant,
such as the NMDA agonist DCS.
The prefrontal cortex is regarded as the central structure of WM
processing
21,24,50, and is known to play a crucial role in enhancing
WM performance
24,51. Incremental improvements in activities of the
middle frontal gyrus and superior and inferior parietal cortices by
repetitiveWMtraining
11arelessspecifictovariousstimulithatdrive
cognitive performance
52–54. Further, repetitive training on a spatial
n-back task improves not only spatial n-back performance but also
auditoryn-backperformance,enhancingthedevelopmentofgeneral
fluidintelligence
55.GiventhatWMcapacityisanimportantfactorin
Figure 4 | Changes in working memory (WM) capacity between and
within testing sessions in experimental groups on the semidiurnal
schedule (12-h interval between testing sessions). (A) WM capacity
significantly improved (p , 0.005) between the training and retest sessions
forgroupsC–F.Lightanddarkgreenbarsrepresentn-backaccuracylevelsat
the training and retest sessions, respectively. (B) Inter-session differences in
n-backaccuracylevelsingroupsC–F.Ingroupsreceivingtheplacebo(PLC)
treatment (C, D), sleep seemed to facilitate improvement in accuracy more
than wakefulness. However, improvements in n-back accuracy levels were
similar ingroupsreceivingthe D-cycloserine (DCS)treatment, regardlessof
whethertheyfollowedtrainingwithaperiodofwakefulness(F)orsleep(E).
Blueandyellowbarsrepresentchangesinn-backaccuracylevelduringsleep
and wake periods, respectively. The heights of the bars and error bars
represent the mean and SEM, respectively. The crosses ({) indicate a trend
toward significance (p , 0.05).
www.nature.com/scientificreports
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55 and
regulationofemotions
56,itislikelythattheadministrationofNMDA
agonists with WM training could facilitate potential cognitive ability
by boosting the available capacity of prefrontal learning
57,58.
Although we instructed study participants to keep regular sleep-
wake habits, it is possible that our results were confounded by differ-
encesinpre- orpost-training sleep patternsorbypotentialcircadian
effects. However, both pre- and post-training sleep durations were
similar across groups. Thus, we believe that our findings accurately
reflect sleep- and wakefulness-related neural processes associated
with skill learning and may therefore be helpful for developing tech-
niques for strengthening the cognitive abilities of children
59,60 and
preventingspecificcognitivedecrementswithaging
61,62.NMDAago-
nists may be useful in the rehabilitation of patients with frontal
dysfunctions, which appear to be closely related to general fluid
intelligence
63,64, and for preventing or treating posttraumatic stress
disorder
65. Before our results can be applied to achieving these goals,
itwillbeimportanttofurtherelucidatetheneuralmechanismofWM
capacity development facilitated by NMDA agonists, at both the
cellular and cortical network levels.
Methods
Participants.Atotalof88right-handedhealthysubjects[21.360.14yearsold(mean
age6standarderrorofthemean);range:20–25yearsold;40females]participatedin
this study. Subjects had no previous history of drug or alcohol abuse or of neuro-
logical, psychiatric, or sleep disorders, and maintained a constant sleep schedule
validated by self-recorded sleep-logs. They were instructed to be drug-, alcohol-, and
caffeine-free for 24 h before and during the study period. Women in the follicular
phase of their regular menstrual cycles were included in the study. All study proce-
dures followed the guidelines outlined in the Declaration of Helsinki. The study
protocol was approved by the Intramural Research Board of the National Center of
NeurologyandPsychiatryandallsubjectsprovidedwritteninformedconsentpriorto
participating in the study.
Experimental Design. Randomized, blind, placebo-controlled procedures were
applied for diurnal and semidiurnal group partition tests (Fig. 1). Random allocation
of subjects to 6 different groups (groups A–F) eliminated biases for age (F5,82 5 1.37,
p50.24)andsex(x
252.35,p50.799).Nineteensubjectswereinitiallyrecruited,but
2 women were omitted because they had irregular menstrual cycles. Subjects in
groups A and B were assigned to a diurnal experimental schedule, which consisted of
an initial training session and a retest session. Subjects in groups C–F were placed on
semidiurnal experimental schedules, some of which (C, E) included a sleep period,
and some of which (D, F) did not. We examined the general effect of DCS on the
improvement of WM capacity across 24 h by comparing groups A and B. Moreover,
toexaminewhetherDCSaffectsWMcapacitybyinteractingwithsleep,wecompared
groups C–F.
During each test session, subjects performed a spatial n-back WM task (n 5 1–7).
Allpost-sleepretestswereperformedatleast1 hafterawakeningtoavoidtheeffectof
sleep inertia
66. Each subject had a sequence of task rehearsals (n 5 0–2) prior to
receiving medication. Medication (100 mg of either encapsulated DCS or a lactose
placebo) was administered on an empty stomach 2 h prior to the training session.
Subjects were not able to judge whether they received DCS or placebo. Given that the
time course of the plasma concentration and the plasma half-life for DCS are within
1h and 8–12 h, respectively
40, this timing ensured that subjects’ performances
(including potential delayed learning) would be affected by the drug. DCS was
administeredtosubjectsingroupsB(21.160.34yearsold;8femalesand8males),D
(21.560.43yearsold;4females and9males), andF(21.0 60.26yearsold;7females
and 9 males). Previous clinical studies have shown that the 100-mg dose used here
facilitates the extinction of pathological fear memory in humans
67–69. Subjects in
groups A (21.8 6 0.41 years old; 8 females and 6 males), C (20.7 6 0.24 years old;
7 females and 7 males), and E (21.5 6 0.34 years old; 6 females and 9 males) were
given the lactose placebo.
The amount of pre-training sleep for each subject was estimated by the self-
recorded sleep-log. The amount of overnight post-training sleep for each subject in
experimental groups A, B, C, and E was estimated with an ambulatory wrist activity
recorder (Actiwatch-L, Mini-Mitter Co., Inc., Bend, OR, USA).
Working Memory Task. We utilized a spatial variant of the n-back WM task widely
used to measure spatial WM with a sustained attention component
7–10.T h en-back
WMtaskhad7increasinglevelsofdifficulty(n51–7).Fourlargedotspresentedina
single horizontal row were displayed on a computer screen, indicating the 4 possible
placeswhereastimuluscouldappear
12.Thestimulusconsistedof1of4dotschanging
color. Subjects were instructed to respond to the stimulus by using their right fingers
to push 1 of 4 spatially corresponding buttons on a response box as quickly and as
accurately as possible before the next stimulus appeared. Responses were to be made
after a delay of n (load level) stimuli.
At each training or retest session, subjects performed 3 trials separated by
60,000 ms of inter-trial intervals. Each trial consisted of 7 load levels. The different
load levels, which were shown before stimulation began, ran in a block of 20 1 n
stimuli each; thus, 20 responses were obtained at each load level. Each stimulus was
displayed in a randomized order for 1500 ms with 500 ms of inter-stimulus interval;
thus, each block lasted a total of 42,500–54,500 ms. Subjects completed all 7 load
levelsinascendingorderofdifficultyat15,000 msintervalsineachtrial,andrepeated
this sequence 3 times (trials) during each session. Performance was evaluated using
the average percentage of correct responses (accuracy) at each load level. The
detection threshold for a given session was defined as the maximum n-back accuracy
level at which the subject’s accuracy exceeded at least 80%. The maximum n-back
accuracy level in the third trial was used to indicate the current WM capacity in
each session.
At each training and retesting point, all subjects performed a psychomotor vigil-
ance task (PVT), which is a measure of the psychomotor vigilance level
39. The PVT
involvedpressingabuttoninresponsetothepresentationofastimulus(areddot)on
a computer screen. Several stimuli were randomly presented for 2000–10,000 s
duringa5-minperiod,whichresultedinatotalof30–45responses.Bymeasuringthe
simple response time (SRT), we could count the number of lapses (response time $
500 ms),whichwereindicativeofsleepiness,fatigue,anddrug-inducedimpairments.
A subjective questionnaire was also utilized to determine whether, and what type, of
psychomotor side effects were caused by the DCS.
Statistics. Three-way factorial ANOVAs were applied to detect the effects of group
(A–B), session (training-retest), and sex (women or men) on PVT performances.
Four-way factorial ANOVA was also applied to assay for effects of session, medica-
tion(placeboorDCS),inter-sessionschedule(sleepvs.wakefulness),andsexonPVT
performances of groups C–F. Two-way factorial ANOVA and three-way factorial
ANOVAwereappliedtodetecttheeffectsofgroupandsexonamountofpre-training
(groups A-B) sleep and pre-training (groups C–F) sleep, respectively. Two-way fac-
torial ANOVAs were applied to detect the effects of group and sex on post-training
(group A vs. B and group C vs. E) sleep.
Todetecttheeffectsofrepetitivetraining(firsttothirdblocks),medication,andsex
on the n-back accuracy level, we used three-way repeated measures ANOVA with
Bonferroni post hoc tests. A three-way factorial ANOVA was used to measure the
effects of DCS on delayed improvement of WM capacity across 24-h intervals; this 2
(groups) 3 2 (sessions) 3 2 (sexes) analysis allowed us to examine the impact of
session (training vs. retest), medication, and sex on the n-back accuracy level within
groups A and B. An unpaired t-test was also applied to compare improvements in
n-back accuracy level (retest minus initial training) in groups A and B.
We used a four-way factorial ANOVA to assay for effects of session, medication,
inter-session schedule (sleep vs. wakefulness), and sex on the n-back accuracy level
within groups C–F. This 4 (groups) 3 2 (sessions) 3 2 (schedules) 3 2 (sexes)
comparison allowed us to determine the impact of DCS on delayed improvement of
WM capacity across 12-h intervals involving either sleep or wakefulness. Two-way
factorial ANOVAs with Bonferroni’s post hoc tests were also applied to detect the
effects of medication and schedule on the improvement of n-back accuracy level
(retest minus initial training).
Results are shown as mean 6 SEM. Significance was defined as p , 0.05 (adjusted
to 0.0167 in the Bonferroni post hoc analysis).
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